pharmaphorum

JANUARY 25, 2023

A data-enriched approach enables sales and marketing teams to develop targeted strategies that focus on healthcare provider (HCP) preferences while meeting budget allocations – which will be especially important in 2023 as companies try to maintain budgets in an inflationary economy.

Marketing 98

Marketing Sales Retail Management 98

PM360

JUNE 11, 2022

Traditionally, the role of Medical Affairs is to generate scientifically accurate content for disease state education or on-labeling messages to healthcare providers (HCPs). Observationally, this is truer for the small and mid-size pharma and biotech companies than for larger pharma companies. One example is Bloom et al.’s

Patients 98

Patients Medical Education Government 98

Clarivate

APRIL 24, 2023

Here’s a look at some of the recent mergers that are reshaping the business of healthcare delivery and payment in the United States – who the players are and how their moves will impact drug development and launch strategies going forward. healthcare organizations Company Founded Type No. Key acquisitions by U.S.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

World of DTC Marketing

SEPTEMBER 17, 2020

While there are lots of reasons for this the silence of healthcare providers is a huge reason. The adult obesity rate passed 40 percent nationally for the first time according to the 2017–2018 National Health and Nutrition Examination Survey (NHANES), a 26 percent jump from 2007–2008.

Healthcare 242

Healthcare Healthcare Insurance Healthcare Provider 242

Healthcare Success

MAY 9, 2022

We know that today’s healthcare consumers want instant and accessible services. . The QR code allows hospitals and healthcare providers to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . The Resurgence of QR Codes in Health & Pharma.

Leads 109

Leads Patients Healthcare Provider Healthcare 109

Impetus Digital

MARCH 15, 2024

Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017).

Recruitment 78

Recruitment Patients Healthcare Provider Healthcare 78

Healthcare Success

MAY 9, 2022

We know that today's healthcare consumers want instant and accessible services. . The QR code allows hospitals and healthcare providers to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . The Resurgence of QR Codes in Health & Pharma. Elderly care.

Leads 52

Leads Patients Healthcare Provider Healthcare 52

Pharma Marketing Network

JUNE 8, 2020

RJ (PMN): Hi this is RJ Lewis, your host of the pharma marketing network podcast and I’m excited today to have with me a couple of executives from Klick Health to talk about CCPA. RJ (PMN): Why does this impact health and pharma more than other industries like automotive, or beauty products etc. Welcome to the podcast!

Marketing 40

Marketing Pharma Healthcare Healthcare 40

pharmaphorum

JANUARY 29, 2023

Let me explain our four reasons for making healthcare a priority in greater detail: Firstly, healthcare’s historic acceleration means investments, both public and private, and revenues are likely to grow steadily. Overall, the industry is steadily becoming more consolidated and is likely to continue to do so.

Healthcare 98

Healthcare Healthcare Manufacturing Marketing 98

Pharmaceutical Technology

SEPTEMBER 26, 2022

Both Sandoz and Novartis are internationally renowned pharma companies, with a combined 34 production facilities worldwide. On 27 March 2018, GlaxoSmithKline (GSK) (Brentford, UK) announced that it had reached an agreement with Novartis for the buyout of Novartis’ 36.5% stake in their consumer healthcare joint venture for $13bn.

Competition 64

Competition Manufacturing Marketing Distribution 64

PM360

NOVEMBER 21, 2022

The decrease in detailing from drug representatives to pharmacies that Edmundson mentions can be attributed to COVID-19, which placed limitations on in-person visitations by sales reps to healthcare providers. When it comes to pharma marketing, however, conversion should not be considered the last stage of the funnel.

Marketing 52

Marketing Education Retail Prescription 52